2020
DOI: 10.1101/2020.05.13.089086
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Altered oligodendroglia and astroglia in chronic traumatic encephalopathy

Abstract: Chronic traumatic encephalopathy (CTE) is a progressive tauopathy found in contact sport athletes, military veterans, and others exposed to repetitive head injury (McKee et al. 2009(McKee et al. , 2013(McKee et al. , 2016Omalu et al. 2005Omalu et al. , 2006Martland 1928;Critchley 1949). White matter atrophy and axonal loss have been reported in CTE but have not been characterized on a molecular or cellular level (McKee et al. 2013;Holleran et al. 2017;Hsu et al. 2018). Here, we report 24,735 single nucleus RNA… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 70 publications
(116 reference statements)
0
1
0
Order By: Relevance
“…Over the last 20 years, our focus on astrocytic dysfunction and pathology has enabled significant progress in an area of research that holds great promise for the treatment of a number of brain disorders. The identification of ARTAG in 2016 [ 2 ] marks a significant milestone in this journey and there is now good conceptual evidence for a link between ARTAG pathology, particularly GFAs, as a precursor to FTLD-tau and accumulating evidence of the importance of TSAs in the pathogenesis of CTE [ 88 , 102 , 103 ]. Whilst encouraging, there are still many knowledge gaps and further research is required to answer a number of fundamental questions pertaining to the etiology of ARTAG, its clinical significance and its role in neurodegeneration.…”
Section: Discussionmentioning
confidence: 99%
“…Over the last 20 years, our focus on astrocytic dysfunction and pathology has enabled significant progress in an area of research that holds great promise for the treatment of a number of brain disorders. The identification of ARTAG in 2016 [ 2 ] marks a significant milestone in this journey and there is now good conceptual evidence for a link between ARTAG pathology, particularly GFAs, as a precursor to FTLD-tau and accumulating evidence of the importance of TSAs in the pathogenesis of CTE [ 88 , 102 , 103 ]. Whilst encouraging, there are still many knowledge gaps and further research is required to answer a number of fundamental questions pertaining to the etiology of ARTAG, its clinical significance and its role in neurodegeneration.…”
Section: Discussionmentioning
confidence: 99%